Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Exp Cell Res ; 173(2): 379-87, 1987 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2961586

RESUMO

The differential metabolic effects of three nicotinamide analogs, 6-aminonicotinamide, 3-aminobenzamide, and 5-methylnicotinamide, were analyzed in mitogen-stimulated preparations of human T lymphocytes. Mitogen stimulation with the phorbol ester TPA and a monoclonal antibody to the T3 cell surface antigen caused an increase in cellular NAD and ATP levels and a marked increase in glucose metabolism as demonstrated by an increase in cellular levels of glucose 6-phosphate and a sevenfold increase in radioactive CO2 formation from [l-14C]glucose. 6-Aminonicotinamide had drastic inhibitory effects on the mitogen-stimulated increases in NAD and ATP levels as well as on the metabolism of glucose. Treatment of the mitogen-stimulated cells with 6-aminonicotinamide also caused a marked increase in cellular levels of 6-phosphogluconate, suggesting inhibition of the hexose monophosphate shunt at 6-phosphogluconate dehydrogenase. Radioactive CO2 formation from [6-14C]glucose showed that metabolism through the tricarboxylic acid cycle was not used to compensate for the inhibition of the hexose monophosphate shunt pathway. Treatment of cells with 3-aminobenzamide had the opposite effect of 6-aminonicotinamide in that cellular NAD levels increased, presumable due to inhibition of poly(ADP-ribose) polymerase. 3-Aminobenzamide did not interfere with ATP or glucose 6-phosphate levels and did not cause significant elevations of 6-phosphogluconate. Thus, 6-aminonicotinamide appears to have direct inhibitory effects on the synthesis of both pyridine nucleotides and poly(ADP-ribose), whereas 3-aminobenzamide has its major inhibitory effect on poly(ADP-ribose) synthesis. 5-Methylnicotinamide also interferes with the mitogen-stimulated increase in NAD levels but not as effectively as 6-aminonicotinamide. The alterations in pyridine nucleotide metabolism resulting from treatment with these nicotinamide analogs can produce drastic and diverse alterations in pathways of glucose utilization and energy generation.


Assuntos
Ativação Linfocitária/efeitos dos fármacos , NADP/sangue , NAD/sangue , Niacinamida/análogos & derivados , Linfócitos T/efeitos dos fármacos , 6-Aminonicotinamida/farmacologia , Trifosfato de Adenosina/sangue , Benzamidas/farmacologia , Dióxido de Carbono/sangue , Gluconatos/sangue , Glucose-6-Fosfato , Glucofosfatos/sangue , Humanos , Niacinamida/farmacologia , Linfócitos T/metabolismo , Acetato de Tetradecanoilforbol/farmacologia
2.
J Clin Invest ; 79(6): 1558-63, 1987 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-3108318

RESUMO

The possibility that corticosteroid cytotoxicity could be mediated by activation of poly(ADP-ribose) polymerase and consequent depletion of NAD and ATP was evaluated in steroid-sensitive S49.1 and steroid-resistant S49.143R mouse lymphoma cells and in lymphocytes from a patient with chronic lymphocytic leukemia. All cell types were shown to have the enzyme poly(ADP-ribose) polymerase and to increase activity in response to DNA strand breaks. Incubation of susceptible cells with 1 microM dexamethasone resulted in DNA strand breaks. Susceptible cells also showed a dose-dependent decrease in NAD and ATP that preceded loss of cell viability. These studies suggest that steroid-induced cytotoxicity in susceptible lymphocytes is due to the presence of DNA strand breaks that activate poly(ADP-ribose) polymerase to a sufficient degree to consume cellular pools of NAD with a consequent depletion of ATP and loss of cell viability.


Assuntos
Trifosfato de Adenosina/fisiologia , Dano ao DNA , Dexametasona/farmacologia , Linfócitos/efeitos dos fármacos , NAD/fisiologia , Açúcares de Nucleosídeo Difosfato/metabolismo , Poli Adenosina Difosfato Ribose/metabolismo , Animais , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Reparo do DNA , DNA de Neoplasias/efeitos dos fármacos , Ativação Enzimática , Humanos , Leucemia Linfoide , Linfócitos/metabolismo , Linfoma , Camundongos , Poli(ADP-Ribose) Polimerases/metabolismo
3.
Exp Cell Res ; 169(1): 149-57, 1987 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-3102266

RESUMO

Mitogen stimulation of purified human T-lymphocytes with the phorbol ester 12-O-tetradecanoyl, phorbol-13-acetate (TPA) and a monoclonal antibody to the T3 cell surface antigen caused a 6-11-fold increase in cellular levels of poly(ADP-ribose) polymerase, a 6-20-fold amplification of cellular NAD+ levels and a 3-21-fold increase in NADP+ levels. Treatment of the cells with a combination of the two mitogenic signals also caused a 5-20-fold increase in NMN pyrophosphorylase activity, a 3-14-fold increase in ATP-NMN adenylyl transferase activity, and a 5-13-fold increase in NAD kinase activity. This is the first report showing induction of these three enzymes as part of the mitogenic response in purified human T-lymphocytes. Maximum increases in activity of each of these three enzymes required the combined presence of TPA and monoclonal antibody to human T-cell T3 antigen anti-T3. Analysis of the relative enzyme levels indicates that NMN pyrophosphorylase is the rate-limiting enzyme for NAD synthesis and NAD kinase is the rate-limiting enzyme for NADP synthesis.


Assuntos
Ativação Linfocitária , NADP/biossíntese , NAD/biossíntese , Linfócitos T/imunologia , Anticorpos Monoclonais/imunologia , Antígenos de Superfície/análise , Humanos , Cinética , Poli(ADP-Ribose) Polimerases/biossíntese , Linfócitos T/efeitos dos fármacos , Linfócitos T/metabolismo , Acetato de Tetradecanoilforbol/farmacologia
4.
Biochem Biophys Res Commun ; 134(1): 227-32, 1986 Jan 14.
Artigo em Inglês | MEDLINE | ID: mdl-3080986

RESUMO

In this communication we show that activation of poly(ADP-ribose) polymerase by DNA damage can produce drastic alterations in carbohydrate metabolism. We examined alterations in NAD+, NADP+, ATP and glucose-6-phosphate in L1210 murine leukemia cells, following exposure to different concentrations of N-methyl-N'-nitro-N-nitrosoguanidine. Treatment of cells with 20 micrograms/ml MNNG produced rapid depletion of NAD+ and ATP. The G-6-P pool showed a biphasic change: first the pool size decreased, then increased to a level greater than that present in control cells. Nicotinamide treatment prevented the total depletion of NAD+ and this in turn helped preserve the ATP pools and prevented the biphasic alteration in G-6-P pool sizes.


Assuntos
Glucose/metabolismo , Poli(ADP-Ribose) Polimerases/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Linhagem Celular , Ativação Enzimática , Glucose-6-Fosfato , Glucofosfatos/metabolismo , Leucemia L1210/metabolismo , Metilnitronitrosoguanidina/farmacologia , Camundongos , NAD/metabolismo , NADP/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...